Drug Type Small molecule drug |
Synonyms CRD-5500, TAK676 |
Target |
Mechanism STING1 stimulants(Stimulator of interferon genes stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | US | 28 Dec 2023 | |
Solid tumor | Phase 1 | US | 28 Dec 2023 | |
Solid tumor | Phase 1 | US | Spera Pharma, Inc.Startup | 28 Dec 2023 |
Solid tumor | Phase 1 | CN | 28 Dec 2023 | |
Solid tumor | Phase 1 | CN | Spera Pharma, Inc.Startup | 28 Dec 2023 |
Solid tumor | Phase 1 | CN | 28 Dec 2023 | |
Solid tumor | Phase 1 | AT | 28 Dec 2023 | |
Solid tumor | Phase 1 | AT | 28 Dec 2023 | |
Solid tumor | Phase 1 | AT | Spera Pharma, Inc.Startup | 28 Dec 2023 |
Solid tumor | Phase 1 | CA | 28 Dec 2023 |